Novavax, Inc. (NASDAQ: NVAX) reported Q1 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $4.64 million versus the consensus estimate of $7.36 million.

For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.

Earnings